AKT1 and Insulin resistance: In T2DM, insulin resistance has been shown to inhibit protein synthesis by inhibiting the IGF-1-PI3K-AKT/PKB-mTOR pathway, and to activate the UPS and ALP through the IGF-1-AKT-FoxO signaling pathway, thereby promoting muscle atrophy.